Case Report: Primary catastrophic antiphospholipid syndrome in a pediatric patient with cerebral venous sinus thrombosis as the first manifestation

被引:0
作者
Xu, Lingyang [1 ]
Wu, Jing [1 ]
Wang, Haidong [1 ]
Yang, Baowang [1 ]
机构
[1] Second Hosp Lanzhou Univ, Pediat Intens Care Unit, Lanzhou, Peoples R China
关键词
case report; primary catastrophic antiphospholipid antibody syndrome; multiple thrombus; children; cerebral venous sinus thrombosis; INTERNATIONAL CONSENSUS STATEMENT; CLASSIFICATION CRITERIA;
D O I
10.3389/fped.2024.1491095
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Antiphospholipid syndrome (APS) is an autoimmune disease characterized by recurrent vascular thrombotic events. Catastrophic APS (CAPS), which can result in multiple organ failure and even death, is the most severe manifestation of APS. Herein, we report the case of a pediatric patient with CAPS, including the clinical course, diagnosis, and treatment, with the goal of expanding the literature on this condition, as reports of CAPS in pediatric patients are rare.Case presentation A 7-year-old girl presented with cranial hypertension. She was initially admitted to the hospital with a diagnosis of cerebral venous sinus thrombosis (CVST) and was discharged following symptom improvement. However, only 3 days later, the patient was re-presented with cranial hypertension and multiple thromboses and was ultimately diagnosed with CAPS based on multidisciplinary consensus. Despite treatment with a series of anticoagulation and thrombolytic therapies, the child's condition progressed rapidly, and she eventually died of pulmonary embolism.Conclusion CAPS in children is rare and associated with a high mortality rate, making early recognition and diagnosis critical but difficult. Based on the presented case, we recommend routine screening for antiphospholipid antibodies in children with CVST without obvious triggers, or a multidisciplinary collaboration, to facilitate the early diagnosis of CAPS.
引用
收藏
页数:9
相关论文
共 19 条
[1]  
Agnelli G., 2007, Handbook on Cerebral Venous Thrombosis, P16
[2]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[3]   The catastrophic antiphospholipid (Asherson's) syndrome [J].
Asherson, Ronald A. .
AUTOIMMUNITY REVIEWS, 2006, 6 (02) :64-67
[4]   2023 ACR/EULAR antiphospholipid syndrome classification criteria [J].
Barbhaiya, Medha ;
Zuily, Stephane ;
Naden, Ray ;
Hendry, Alison ;
Manneville, Florian ;
Amigo, Mary-Carmen ;
Amoura, Zahir ;
Andrade, Danieli ;
Andreoli, Laura ;
Artim-Esen, Bahar ;
Atsumi, Tatsuya ;
Avcin, Tadej ;
Belmont, Michael H. ;
Bertolaccini, Maria Laura ;
Branch, D. Ware ;
Carvalheiras, Graziela ;
Casini, Alessandro ;
Cervera, Ricard ;
Cohen, Hannah ;
Costedoat-Chalumeau, Nathalie ;
Crowther, Mark ;
de Jesus, Guilherme ;
Delluc, Aurelien ;
Desai, Sheetal ;
De Sancho, Maria ;
Devreese, Katrien M. ;
Diz-Kucukkaya, Reyhan ;
Duarte-Garcia, Ali ;
Frances, Camille ;
Garcia, David ;
Gris, Jean-Christophe ;
Jordan, Natasha ;
Leaf, Rebecca K. ;
Kello, Nina ;
Knight, Jason S. ;
Laskin, Carl ;
Lee, Alfred I. ;
Legault, Kimberly ;
Levine, Steve R. ;
Levy, Roger A. ;
Limper, Maarten ;
Lockshin, Michael D. ;
Mayer-Pickel, Karoline ;
Musial, Jack ;
Meroni, Pier Luigi ;
Orsolini, Giovanni ;
Ortel, Thomas L. ;
Pengo, Vittorio ;
Petri, Michelle ;
Pons-Estel, Guillermo .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) :1258-1270
[5]   Pediatric catastrophic antiphospholipid syndrome: Descriptive analysis of 45 patients from the "CAPS Registry" [J].
Berman, Horacio ;
Rodriguez-Pinto, Ignasi ;
Cervera, Ricard ;
Gregory, Simone ;
de Meis, Ernesto ;
Maia Rodrigues, Carlos Ewerton ;
Aikawa, Nadia Emi ;
de Carvalho, Jozelio Freire ;
Springer, Janusz ;
Niedzwiecki, Maciej ;
Espinosa, Gerard .
AUTOIMMUNITY REVIEWS, 2014, 13 (02) :157-162
[6]   A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection [J].
Canpolat, Nur ;
Topal, Nilufer ;
Civilibal, Mahmut ;
Caliskan, Salim ;
Sever, Lale ;
Kasapcopur, Ozgur ;
Baserer, Tahire ;
Arisoy, Nil .
CLINICAL PEDIATRICS, 2008, 47 (06) :593-597
[7]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[8]   Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease [J].
Elhasid, R ;
Rowe, JM ;
Berkowitz, D ;
Ben-Arush, M ;
Bar-Shalom, R ;
Brik, R .
BONE MARROW TRANSPLANTATION, 2004, 33 (12) :1257-1259
[9]   Prognosis of cerebral vein and dural sinus thrombosis - Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) [J].
Ferro, JM ;
Canhao, P ;
Stam, J ;
Bousser, MG ;
Barinagarrementeria, F .
STROKE, 2004, 35 (03) :664-670
[10]   A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS) [J].
Finazzi, G ;
Marchioli, R ;
Brancaccio, V ;
Schinco, P ;
Wisloff, F ;
Musial, J ;
Baudo, F ;
Berrettini, M ;
Testa, S ;
D'Angelo, A ;
Tognoni, G ;
Barbui, T .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) :848-853